Comparison of patients from Nigeria and the USA highlights modifiable risk factors for sickle cell anemia complications. - Wikidata - wikimedia - TriplyDB

Comparison of patients from Nigeria and the USA highlights modifiable risk factors for sickle cell anemia complications.

Comparison of patients from Nigeria and the USA highlights modifiable risk factors for sickle cell anemia complications.

http://www.wikidata.org/entity/Q34164732

about

Vitamin D levels are low in adult patients with sickle cell disease in Jamaica and West Africa.Neurologic complications of sickle cell disease in Africa: A systematic review and meta-analysis.Genetics of Sickle Cell-Associated Cardiovascular Disease: An Expert Review with Lessons Learned in Africa.Rates and risk factors of hypertension in adolescents and adults with sickle cell anaemia in Tanzania: 10 years' experience.Prevalence of relative systemic hypertension in adults with sickle cell disease in Ghana.Comparative study of the growth and nutritional status of Brazilian and Nigerian school-aged children with sickle cell disease.Prescription audit in a paediatric sickle cell clinic in South-West Nigeria: A cross-sectional retrospective study.

P2860

Q34084995-450C1F04-328D-4714-B1B9-3D5D8EDFC139 Q38597215-0712B103-506B-44D2-9206-913921D25661 Q38977617-099C8E6E-E31C-4A1C-BF09-F97207CC4BFA Q39369618-AD189829-C0B7-4BAC-BE84-D13016873A3C Q47180439-8A871B96-F65E-4729-B5DF-6127E977373C Q47242133-4D8EBF10-0AAB-4006-A2E8-883603BD9437 Q55379739-9FE3A2D0-3191-4D0F-8BBA-0F52BA06A01D

P2860

Comparison of patients from Nigeria and the USA highlights modifiable risk factors for sickle cell anemia complications.

http://www.wikidata.org/entity/Q34164732

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Comparison of patients from Ni ...... kle cell anemia complications.

@ast

Comparison of patients from Ni ...... kle cell anemia complications.

@en

Comparison of patients from Ni ...... kle cell anemia complications.

@nl

type

label

Comparison of patients from Ni ...... kle cell anemia complications.

@ast

Comparison of patients from Ni ...... kle cell anemia complications.

@en

Comparison of patients from Ni ...... kle cell anemia complications.

@nl

prefLabel

Comparison of patients from Ni ...... kle cell anemia complications.

@ast

Comparison of patients from Ni ...... kle cell anemia complications.

@en

Comparison of patients from Ni ...... kle cell anemia complications.

@nl

P1433

Q34164732-01677337-5DF1-4020-A491-1879EDE071BE

P1476

Q34164732-F433540A-62B2-42E4-9B92-74CAFA86B248

P2093

Q34164732-2276A17A-D92E-4051-B644-27B0A78551C9

Q34164732-76719A6E-89F6-4E6F-ABB6-020FC55D5417

Q34164732-9220EB74-936B-4935-9F61-4D2FEA1FA8CA

Q34164732-9239D36F-3C5F-4B2A-B169-360A782F0CBF

Q34164732-9DF09536-0BD6-47F2-8D5D-CCBE677F44F0

Q34164732-EAA46F6E-976F-4C3A-A7AC-67B6E1A4220A

P2860

Q34164732-154FCC3C-29EF-4733-87AE-3952D72C3B94

Q34164732-206811C1-1C32-4EDA-8DDB-FE1088617EFE

Q34164732-26A490F6-132C-43D0-93D2-6E1BFC16A828

Q34164732-2DB25D89-96A3-4F24-84D3-A2E8F229A6A1

Q34164732-37D8ECAA-21E3-4159-90D8-38DBF80D21E2

Q34164732-4AD84E73-9EF9-486F-85FB-FD6221AEF84D

Q34164732-4DA7B731-E9E3-4F6E-A3FA-7C7C42AD8C35

Q34164732-510C1BA6-A9B9-4936-A8D2-00FB5FFF9B02

Q34164732-58E46BB3-0BD2-485E-85CF-C1B908CE8F1F

Q34164732-677D160E-2C47-4AB0-AC05-70A91E7E922E

P304

Q34164732-9C42E3B9-481E-49D8-BB77-8DB9A8D52115

P31

Q34164732-9A62989C-5637-433C-AAFE-F120AF012434

P356

Q34164732-2E5A8C03-2FC4-4355-B292-65A117CD61D2

P433

Q34164732-136518F1-0415-42B0-889D-A435C32A4404

P478

Q34164732-334D0C8E-4EA6-4F00-999B-5845923D1FCF

P50

Q34164732-43461659-4380-48C9-B21E-0C79C088EAFE

Q34164732-D7FE849D-B7D3-4A30-A1CD-8F0705D3956E

P577

Q34164732-32412EE8-BC27-4C07-888A-134B382CEF88

P5875

Q34164732-58E05D09-E206-4ECE-940D-B2F593F02A1F

P698

Q34164732-BBB4AFC3-AD4C-48B7-8FDC-030624E1043D

P921

Q34164732-5DB60481-920D-41AE-A4B0-4B8DE860970D

Q34164732-ACCD6CE4-EECD-4920-8BD7-F78CA80D9AAF

P932

Q34164732-52365EAD-102F-4A24-98A2-7073D0F1D429

P356

03630269.2014.927363

P1433

P1476

Comparison of patients from Ni ...... kle cell anemia complications.

@en

P2093

Babatunde Salako

http://www.w3.org/2001/XMLSchema#string

Bamidele O Tayo

http://www.w3.org/2001/XMLSchema#string

Jennifer E Layden

http://www.w3.org/2001/XMLSchema#string

Richard S Cooper

http://www.w3.org/2001/XMLSchema#string

Santosh L Saraf

http://www.w3.org/2001/XMLSchema#string

Victor R Gordeuk

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Male gender, increased blood viscosity, body mass index and triglyceride levels are independently associated with systemic relative hypertension in sickle cell anemia.

Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency

Decades after the cooperative study: a re-examination of systemic blood pressure in sickle cell disease.

Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report.

Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy.

Current sickle cell disease management practices in Nigeria.

P304

236-243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/03630269.2014.927363

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

Titilola S Akingbola

P577

2014-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263207803

http://www.w3.org/2001/XMLSchema#string

P698

24941131

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

4161131

http://www.w3.org/2001/XMLSchema#string